B55.0
Visceral leishmaniasis
Clinical Classification Guidelines
Inclusion Terms
- Kala-azar
- Post-kala-azar dermal leishmaniasis
Medical Intelligence & Overview
Visceral leishmaniasis, also known as kala-azar, is a severe infectious disease caused by the Leishmania parasite. It primarily affects internal organs such as the spleen, liver, and bone marrow. If left untreated, it can be fatal. Post-kala-azar dermal leishmaniasis is a skin condition that may occur after successful treatment of kala-azar. Understanding the disease, its causes, symptoms, and treatment options can help in early recognition and management.
Causes & Symptoms
Clinical Causes: Infection with the Leishmania parasite, transmitted through the bites of infected female sandflies. Living or traveling in areas where leishmaniasis is common, such as parts of India, East Africa, and South America. Poor housing conditions and inadequate protection from sandfly bites can increase risk. Immunosuppression, which can make individuals more susceptible to infection.
Key Symptoms: Persistent fever that may come and go Enlargement of the spleen and liver (splenomegaly and hepatomegaly) Weight loss and loss of appetite General weakness and fatigue Anemia, leading to pallor and weakness Swelling of lymph nodes Skin changes in post-kala-azar dermal leishmaniasis, such as discoloration or patches of skin
Diagnostic & Treatment
Diagnosis Path: Diagnosis of visceral leishmaniasis involves a combination of clinical evaluation and laboratory tests. These may include:
Treatment Protocols: The primary treatment for visceral leishmaniasis involves specialized medications aimed at killing the parasite. Common options include:
Clinical Advice & FAQs
Billing Guidance
Is B55.0 a billable ICD-10 code?
Yes, B55.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B55.0?
Clinical documentation must specify the nature of Visceral leishmaniasis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference